About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  SMART QUOTES
Smart Quotes      
Astrazeneca Pharma India Ltd.
  Industry : Pharmaceuticals & Drugs
BSE Code 506820
ISIN Demat INE203A01020
Book Value 327.61
NSE Code ASTRAZEN
Dividend Yield % 0.35
Market Cap 228485.00
P/E 124.61
EPS 73.34
Face Value 2  
BSE NSE
17-Sep-2025
Last Price 9139.40
Net Change 120.7
% Change 1.34%
Prev.Close 9018.70
Open 9006.50
High 9191.80
Low 8982.70
Volume 826
Value 7529297
Best Buy 0.00
Best Sell 0.00
Best Quantity 0
Sell Quantity 0
Today's Range 9191.80
52-Week High 10653.05
52-Week Low 6222.35
Today | 1W | 1M | 1Y  
You need to upgrade your Flash Player
Best Bid Best Offer
Quantity 0
Price 0.00
Quantity 0
Price 0.00
Holding Details
More
Latest Corporate Events
Book Closure 03-Sep-18   10-Sep-18  
Dividend 1600 %   18-Jul-25  
Company News
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.